Nadine van Montfoort

assistant-professor

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Nadine van Montfoort is an Assistant Professor at Leiden University Medical Center in the Netherlands. Her research primarily focuses on the development and evaluation of oncolytic virotherapy and immunotherapy for pancreatic cancer, including the study of immune cell interactions and tumor microenvironment influences. She has published several articles exploring the efficacy of novel therapies aimed at enhancing anticancer immunity.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Lukas Hawinkels

Associate professor-Head of research laboratory

Leiden University Medical Center

NETHERLANDS

View details

Evelyne Tassone

Sapienza University of Rome

ITALY

View details

Di Wang

Macquarie University

AUSTRALIA

View details

Rob C. Hoeben

Leiden University Medical Center

NETHERLANDS

View details

Sjoerd H. van der Burg

Leiden University Medical Center

NETHERLANDS

View details

Wouter R. Karthaus

Tenure Track Assistant Professor

EPFL Swiss Finance Institute

SWITZERLAND

View details

Gabri van der Pluijm

Associate Professor & Head of Urology Research Laboratory

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nadine van Montfoort

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer

Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy.

Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma.

Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancer.

Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy.

Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models

Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?

Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses.

Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients.

Collaborators (7)

Lukas Hawinkels

Evelyne Tassone

Di Wang

Rob C. Hoeben

Sjoerd H. van der Burg

Wouter R. Karthaus

Gabri van der Pluijm

Make your next move.